HCM
COCP icon

Highlander Capital Management’s Cocrystal Pharma COCP Stock Holding History

Highlander Capital Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28
Closed -$1K – 686
2019
Q1 		$1K Hold
28
– – ﹤0.01% 668
2018
Q4 		$1K Hold
28
– – ﹤0.01% 674
2018
Q3 		$1K Hold
28
– – ﹤0.01% 701
2018
Q2 		$1K Hold
28
– – ﹤0.01% 727
2018
Q1 		$2K Buy
+28
New +$1.75K ﹤0.01% 718

Other funds holding COCP

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Highlander Capital Management's COCP Position: Q2 2019 in Review

Highlander Capital Management sold out of Cocrystal Pharma (COCP) in Q2 2019, closing a stake of 28 shares — an estimated $1K sold.

Highlander Capital Management first reported a position in COCP in Q1 2018 and held it in 5 quarters. The position peaked at $2K in Q1 2018. 18 funds tracked by Wall St. Rank hold COCP as of Q2 2019.

  • Highlander Capital Management reported no remaining Cocrystal Pharma position as of Q2 2019 after selling out during the quarter.
  • Highlander Capital Management sold 28 Cocrystal Pharma shares in Q2 2019, an estimated $1K.
  • Highlander Capital Management first reported a position in Cocrystal Pharma in Q1 2018 and held it in 5 quarters.
  • Highlander Capital Management's Cocrystal Pharma position peaked at $2K in Q1 2018.
  • 18 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2019.

Based on Highlander Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.